Results 61 to 70 of about 624 (180)

New views of mildronate use for the prevention and correction of impairment of adaptive processes

open access: yesRUDN Journal of Medicine, 2010
Protective and normalizing mildronate action on the level of non enzyme kation proteins in the neurophils and contents of kateholamins in erythrocytes were revealed on the experimental model of the emotional-pain stress.
L V Logunova
doaj  

Effects of mildronate in experimental model of ischemic brain damage in vivo

open access: yes, 2012
Mildronāts (3-(2,2,2-trimetilhidrazīna propionāta dihidrāts) ir L-karnitīna biosintēzes inhibitors un antiišēmisks medikaments. Šī darba mērķis bija noskaidrot mildronāta terapijas ietekmi pēc-insulta periodā, novērtējot motoro, sensorimotoro un ...
Ošeniece, Baiba
core  

Microencapsulation of Mildronate in Biodegradable and Non- Biodegradable Polymers

open access: yes
The extremely high hygroscopicity (solubility in water ≥2 g/ml) of the pharmaceutical preparation mildronate defines specific requirements to both packaging material and storage conditions.
Sokolova, Marina   +6 more
core  

PHARMACEUTICAL CORRECTION OF VASCULAR DISTURBANCES IN PATIENTS WITH ARTERIAL HYPERTENSION

open access: yesРоссийский кардиологический журнал, 2010
Aim: To study vascular stiffness and elasticity, microcirculation (MC) parameters, and mildronate effects in patients with arterial hypertension (AH). Material and methods.
L. A. Khaisheva   +4 more
doaj  

Comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatment

open access: yesРоссийский кардиологический журнал, 2007
The study is focused on comparative effectiveness of myocardial cytoprotectors in chronic heart failure (CHF) treatment. In total, 120 patients with Functional Class (FC) II-III CHF were divided into two groups.
G. G. Semenkova, L. V. Kokoreva
doaj  

Role of Carnitine palmitoiltransferase-1 in mechanisms of action of mildronate

open access: yes, 2011
Mildronāts ir zāļu viela, kas samazina karnitīna koncentrāciju audos, kavējot karnitīna biosintēzi un samazinot tā reabsorbciju nierēs. Karnitīns piedalās garķēžu taukskābju enerģijas metabolismā.
Homka, Aija
core  

Mildronate effect on lipid metabolism in experimetal type 1 diabetes

open access: yes, 2008
Mildronāts ietekmē toksisko starpproduktu uzkrāšanos išēmiskajos audos, kuri radušies β – oksidācijas procesā, tā pasargājot audus no oksidatīvā stresa.
Žengele, Jolanta
core  

Altered Blood Molecular Markers of Cardiovascular Function in Rats after Intrauterine Hypoxia and Drug Therapy. [PDF]

open access: yesCurr Issues Mol Biol, 2023
Popazova O   +4 more
europepmc   +1 more source

Cardioprotective effect of hydroxybenzoic acid ester containing neuroactive acid, compound F-26, in conditions of isoproterenol heart failure in rats

open access: yesResearch Results in Pharmacology
Introduction: Currently, chronic heart failure (CHF) is one of the leading problems of modern healthcare. Its most common manifestation is the deterioration of the inotropic reserves of the heart muscle, which over time leads to decompensation and damage
Valentin Kataev   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy